Skip to Main Content
All Podcasts

Melanoma/Skin Cancer Awareness Month

Transcript

  • 00:00 --> 00:02Funding for Yale Cancer Answers is
  • 00:02 --> 00:04provided by Smilow Cancer Hospital.
  • 00:06 --> 00:08Welcome to Yale Cancer Answers
  • 00:08 --> 00:10with Doctor Anees Chagpar.
  • 00:10 --> 00:12Yale Cancer Answers features the
  • 00:12 --> 00:14latest information on cancer care
  • 00:14 --> 00:15by welcoming oncologists and
  • 00:15 --> 00:17specialists who are on the forefront
  • 00:17 --> 00:19of the battle to fight cancer.
  • 00:19 --> 00:21This week it's a conversation
  • 00:21 --> 00:23about Melanoma and other skin
  • 00:23 --> 00:25cancers with doctor Christine Ko.
  • 00:25 --> 00:27Doctor Ko is a professor of
  • 00:27 --> 00:28dermatology and pathology at the
  • 00:28 --> 00:29Yale School of Medicine.
  • 00:30 --> 00:31Where Doctor Chagpar is a
  • 00:31 --> 00:33professor of surgical oncology.
  • 00:34 --> 00:36So Christine, maybe we can start off
  • 00:36 --> 00:38by you telling us a little bit more
  • 00:38 --> 00:40about yourself and what it is you do.
  • 00:40 --> 00:43Yes, I'm a dermatologist and
  • 00:43 --> 00:45dermatopathologist, so a lot of people
  • 00:45 --> 00:47might understand what a dermatologist is.
  • 00:47 --> 00:49But just in case, a dermatologist
  • 00:49 --> 00:52is a physician who studies and
  • 00:52 --> 00:55examines patients skin, hair, and nails.
  • 00:55 --> 00:57Sort of the outer part of your
  • 00:57 --> 01:00body and your scalp and your nails.
  • 01:00 --> 01:02And a dermatopathologist is
  • 01:02 --> 01:04someone who looks at tissue,
  • 01:04 --> 01:06so the tissue from your
  • 01:06 --> 01:08scalp, hair, nails,
  • 01:08 --> 01:10under the microscope.
  • 01:10 --> 01:12So if you've ever gone to a doctor and
  • 01:12 --> 01:14had a piece of your skin taken off,
  • 01:14 --> 01:16which is called a biopsy,
  • 01:16 --> 01:17and had that sent to a laboratory,
  • 01:17 --> 01:19and then you get a report back,
  • 01:19 --> 01:21that report was created by a
  • 01:21 --> 01:22dermatopathologist or sometimes
  • 01:22 --> 01:24a pathologist without specialized
  • 01:24 --> 01:25expertise in the skin.
  • 01:25 --> 01:27But those are the two main things that I do.
  • 01:28 --> 01:29So you do both.
  • 01:29 --> 01:31You're a dermatologist and a
  • 01:31 --> 01:33dermatopathologist, is that right?
  • 01:33 --> 01:36That's fantastic.
  • 01:36 --> 01:40So tell us a bit more about skin cancers.
  • 01:40 --> 01:43I mean, it seems like you do skin
  • 01:43 --> 01:46cancer all the time and we're now
  • 01:46 --> 01:48celebrating Skin Cancer Awareness Month.
  • 01:48 --> 01:51Talk a little bit about what that
  • 01:51 --> 01:53landscape kind of looks like in terms
  • 01:53 --> 01:55of how common are skin cancers.
  • 01:55 --> 01:58What's the most common type
  • 01:58 --> 02:01of skin cancer we see and how
  • 02:01 --> 02:02is that diagnosed and treated?
  • 02:03 --> 02:06Yes. So skin cancer is really important
  • 02:06 --> 02:09because one in five Americans will have
  • 02:09 --> 02:13a skin cancer by the time they're 70.
  • 02:13 --> 02:17So that's 20%. And so in a nuclear family
  • 02:17 --> 02:20that may typically be that one of those
  • 02:21 --> 02:23people will have a skin cancer.
  • 02:23 --> 02:25The most common type of skin
  • 02:25 --> 02:27cancer is basal cell carcinoma.
  • 02:27 --> 02:29And I know that's a lot of words.
  • 02:29 --> 02:30It's 3 words.
  • 02:30 --> 02:32But I abbreviate it to my patients and
  • 02:32 --> 02:34we abbreviate it among doctors too.
  • 02:34 --> 02:38We just call it B like boy, and 2 C's, BCC.
  • 02:38 --> 02:40And so you can call it that
  • 02:40 --> 02:42even as a patient, BCC.
  • 02:42 --> 02:45And so that's BCC is the most
  • 02:45 --> 02:47common skin cancer for Americans,
  • 02:47 --> 02:49especially lighter or
  • 02:49 --> 02:51fairer skinned Americans.
  • 02:51 --> 02:54And that usually presents,
  • 02:54 --> 02:56as we call it, pearly.
  • 02:56 --> 02:59It might look a little shiny or
  • 02:59 --> 03:02that kind of oyster like Translucence,
  • 03:02 --> 03:04if you think of shellfish with
  • 03:04 --> 03:07sort of blood vessels like red
  • 03:07 --> 03:09little lines going through it.
  • 03:09 --> 03:11And one thing that I often tell my patients
  • 03:11 --> 03:14is that it can bleed relatively easily.
  • 03:14 --> 03:15Like you're just sort of
  • 03:15 --> 03:16washing your face or
  • 03:16 --> 03:18it gets brushed with your clothing
  • 03:18 --> 03:20or something and it
  • 03:20 --> 03:22bleeds a tiny bit or sometimes a lot.
  • 03:22 --> 03:24So that's the most common skin cancer.
  • 03:24 --> 03:27The one cancer that of the
  • 03:27 --> 03:29skin that a lot of people are
  • 03:29 --> 03:31more familiar with is Melanoma.
  • 03:31 --> 03:33And I think that's because of
  • 03:33 --> 03:35really good skin cancer campaigns.
  • 03:35 --> 03:37And people know that it's often a dark
  • 03:37 --> 03:40spot and it might be changing or it
  • 03:40 --> 03:42might be a little irregular in shape.
  • 03:42 --> 03:44And that also I think people are aware
  • 03:44 --> 03:47of because it can really affect
  • 03:47 --> 03:48even younger individuals,
  • 03:48 --> 03:51in their 20s and above.
  • 03:51 --> 03:53So it can affect all ages and
  • 03:53 --> 03:54it can be deadly.
  • 03:54 --> 03:56So I think for good reason
  • 03:56 --> 03:57there have been awareness campaigns
  • 03:57 --> 03:59and people are becoming more and
  • 03:59 --> 04:01more familiar with Melanoma.
  • 04:01 --> 04:04And so let's talk a little bit
  • 04:04 --> 04:06about each of those in turn,
  • 04:06 --> 04:09maybe starting with Melanoma
  • 04:09 --> 04:11since that's the most deadly.
  • 04:11 --> 04:13Tell us a bit more about
  • 04:13 --> 04:15what are the risk factors
  • 04:15 --> 04:17for developing Melanoma,
  • 04:17 --> 04:20is there a screening protocol
  • 04:20 --> 04:22that people should follow,
  • 04:22 --> 04:25who should follow it and so on?
  • 04:26 --> 04:28Yes. So Melanoma is one of
  • 04:28 --> 04:30the most deadly skin cancers.
  • 04:30 --> 04:32There are others that are much more
  • 04:32 --> 04:34rare like Merkel cell carcinoma,
  • 04:34 --> 04:35so I won't talk about those.
  • 04:35 --> 04:39But Melanoma skin cancer screening programs,
  • 04:39 --> 04:43the general recommendation is for
  • 04:43 --> 04:45each individual person to look at
  • 04:45 --> 04:48your skin to do a self skin exam,
  • 04:48 --> 04:50just like women and men are told
  • 04:50 --> 04:53to do breast exams on themselves.
  • 04:53 --> 04:56And so a skin exam actually I tell my patients,
  • 04:56 --> 04:59is relatively easy once you get used to it.
  • 04:59 --> 05:01And all you really have to do is
  • 05:01 --> 05:03ideally have a full length mirror
  • 05:03 --> 05:05but a waist up one
  • 05:05 --> 05:07will do if that's all you have.
  • 05:07 --> 05:10And when you come out of the shower or bath,
  • 05:10 --> 05:11maybe choose the 1st of the month or
  • 05:11 --> 05:13the last of the month or
  • 05:13 --> 05:16the 15th or whatever day works for you.
  • 05:16 --> 05:17And ideally, once a month,
  • 05:17 --> 05:20just look at your skin, all of it,
  • 05:20 --> 05:22including the genital area.
  • 05:22 --> 05:23It's a little harder for women,
  • 05:23 --> 05:25but we can take a mirror and look
  • 05:25 --> 05:28at the genital area as well and
  • 05:28 --> 05:31get used to what spots you really have.
  • 05:31 --> 05:32Some people have very few,
  • 05:32 --> 05:33Some people have a lot and just
  • 05:33 --> 05:35get used to it and anything that
  • 05:35 --> 05:37looks a little weird to you,
  • 05:37 --> 05:38ask your doctor about it.
  • 05:38 --> 05:40So that's a big component.
  • 05:40 --> 05:41I think I advocate that
  • 05:41 --> 05:43people do self skin exams.
  • 05:43 --> 05:46The other thing you can do is you can
  • 05:46 --> 05:49go to your doctor or your dermatologist
  • 05:49 --> 05:51and have the physician do a skin
  • 05:51 --> 05:54exam in which ideally they would look
  • 05:54 --> 05:57at every single part of your body.
  • 05:57 --> 05:59So I will examine under the hair,
  • 05:59 --> 06:00you know, between the hairs.
  • 06:00 --> 06:01If I can do it,
  • 06:01 --> 06:03I will tell people to
  • 06:03 --> 06:05enlist the hairdresser's help if
  • 06:05 --> 06:07they go to a hairdresser or Barber.
  • 06:07 --> 06:09For people that have a good
  • 06:09 --> 06:10healthy amount of hair,
  • 06:10 --> 06:11it can be hard to look in
  • 06:11 --> 06:13between all of that hair,
  • 06:13 --> 06:14and it's easier when it's wet.
  • 06:14 --> 06:16So I'll ask people if they do go to
  • 06:16 --> 06:18a Barber or hairdresser
  • 06:18 --> 06:20if they ever notice anything,
  • 06:20 --> 06:21ask them to take a photo,
  • 06:21 --> 06:23kind of have a general sense of where it is,
  • 06:23 --> 06:25and they can even upload that photo to me
  • 06:26 --> 06:30in an electronic medical record.
  • 06:30 --> 06:32And so then ideally the physician
  • 06:32 --> 06:34will look under the hair,
  • 06:34 --> 06:36in between the hair, the rest of the body,
  • 06:36 --> 06:38the general nails,
  • 06:38 --> 06:40bottoms of the feet,
  • 06:40 --> 06:43so the socks and shoes come off as well.
  • 06:46 --> 06:49Thank you for that really
  • 06:49 --> 06:51thorough description because I think
  • 06:51 --> 06:54that well many of us may have heard,
  • 06:54 --> 06:57yeah, we should look at our skin.
  • 06:57 --> 06:58We don't really think about
  • 06:58 --> 07:00some of those other areas.
  • 07:00 --> 07:02Taking a mirror and looking
  • 07:02 --> 07:05at the genital area is something that
  • 07:05 --> 07:07a lot of people may not think about,
  • 07:07 --> 07:10especially because so much of us
  • 07:10 --> 07:13think about skin cancers and Melanoma
  • 07:13 --> 07:16as being related to sun exposure.
  • 07:16 --> 07:19So in that area, if you haven't
  • 07:19 --> 07:21gone skinny dipping for a while,
  • 07:21 --> 07:24it generally isn't exposed to sunlight,
  • 07:24 --> 07:26but is it still at risk for Melanoma?
  • 07:26 --> 07:27Yes, absolutely.
  • 07:27 --> 07:30I'm glad that you made that comment
  • 07:30 --> 07:33because often my patients and
  • 07:33 --> 07:35friends, family who talk to me
  • 07:35 --> 07:37about skin and skin cancer and
  • 07:37 --> 07:39how and when they should
  • 07:39 --> 07:41be looking at their own skin,
  • 07:41 --> 07:42they often say,
  • 07:42 --> 07:44but I don't go to nude beaches
  • 07:44 --> 07:47or I don't go skinny dipping.
  • 07:47 --> 07:50And absolutely it's a myth and
  • 07:50 --> 07:53that misconception comes from partial truth,
  • 07:53 --> 07:56which is often the case.
  • 07:56 --> 07:57Ultraviolet light,
  • 07:57 --> 07:59sunlight, is a major contributor to
  • 07:59 --> 08:02skin cancer and that's a major reason
  • 08:02 --> 08:05why fairer skin or lighter skin,
  • 08:05 --> 08:07especially skin types that
  • 08:07 --> 08:09burn and virtually don't tan,
  • 08:10 --> 08:12they burn and then they go
  • 08:12 --> 08:13back to the fair skin that they
  • 08:13 --> 08:15had before the burn and they
  • 08:15 --> 08:17don't really become significantly
  • 08:17 --> 08:19darker or tan in any way.
  • 08:19 --> 08:21That's the highest risk skin type
  • 08:21 --> 08:23for skin cancer because there's
  • 08:23 --> 08:24essentially no melanin pigment.
  • 08:24 --> 08:25Melanin is the
  • 08:25 --> 08:28Pigment in the skin that
  • 08:28 --> 08:30creates color that can create a tan and
  • 08:30 --> 08:33with virtually no protection from melanin
  • 08:33 --> 08:35you are at highest risk for skin
  • 08:35 --> 08:38cancer compared to skin that's has
  • 08:38 --> 08:40more melanin in it, but ultraviolet
  • 08:40 --> 08:44light is not the
  • 08:44 --> 08:47only risk factor and another risk
  • 08:47 --> 08:50factor is for example human papilloma
  • 08:50 --> 08:53virus and
  • 08:53 --> 08:55I think that can make sense.
  • 08:55 --> 08:57The way I often translate it to patients is
  • 08:58 --> 08:59you know that cervical cancer or a
  • 08:59 --> 09:02lot of people understand that and
  • 09:02 --> 09:03they know about vaccination of
  • 09:04 --> 09:06younger kids and even up to age 45
  • 09:06 --> 09:08against HPV virus to prevent
  • 09:08 --> 09:11cervical cancer as well as other
  • 09:11 --> 09:13especially genital cancers and oral
  • 09:13 --> 09:15cancers that are related to HPV virus.
  • 09:15 --> 09:16But it's same for the skin.
  • 09:16 --> 09:18And so that genital area or the
  • 09:18 --> 09:20sort of near genital area,
  • 09:20 --> 09:23a risk factor is human papilloma
  • 09:23 --> 09:24virus.
  • 09:24 --> 09:26And so that can be a reason why you
  • 09:26 --> 09:28may have never gone to a nude beach,
  • 09:28 --> 09:30but you can have skin cancer
  • 09:30 --> 09:32in that area as well.
  • 09:33 --> 09:36So does HPV vaccine protect you
  • 09:36 --> 09:39against skin cancers in that area?
  • 09:40 --> 09:41Yes, I think it can.
  • 09:41 --> 09:45And so one thing for example is that
  • 09:45 --> 09:47transplant patients who are
  • 09:47 --> 09:48immunosuppressed because,
  • 09:48 --> 09:50you know, to help them not
  • 09:50 --> 09:52reject the transplanted organ,
  • 09:52 --> 09:54they are at higher risk of skin cancer
  • 09:54 --> 09:56as well as other cancers due to that
  • 09:56 --> 09:58suppression of the immune system that's
  • 09:58 --> 10:01appropriate to keep the
  • 10:01 --> 10:03transplanted organ doing well.
  • 10:03 --> 10:07But especially patients with sort of darker,
  • 10:07 --> 10:08higher skin types,
  • 10:08 --> 10:10they have higher risk of skin cancer
  • 10:10 --> 10:12in those sort of more sun protected
  • 10:12 --> 10:15areas and it is thought to be
  • 10:15 --> 10:16because of human papilloma virus.
  • 10:16 --> 10:19And there are efforts to see if
  • 10:19 --> 10:21vaccination against HPV can reduce
  • 10:21 --> 10:24skin cancers in that population.
  • 10:24 --> 10:26So yes, you're absolutely right that
  • 10:26 --> 10:29HPV induced skin cancers should be
  • 10:29 --> 10:32prevented as well from the HPV vaccine.
  • 10:33 --> 10:35Interesting. So you mentioned
  • 10:35 --> 10:40that people with darker skin with
  • 10:40 --> 10:43more melanin are more likely to
  • 10:43 --> 10:48get these HPV type skin cancers.
  • 10:48 --> 10:51Do we see other differences based
  • 10:51 --> 10:56on race or or skin color in terms
  • 10:56 --> 10:58of how skin cancers present?
  • 10:59 --> 11:01Yes, that's a great question.
  • 11:01 --> 11:04I'm not sure that they're more susceptible
  • 11:04 --> 11:07to HPV induced cancers if they have
  • 11:07 --> 11:09darker skin or you know higher type skin.
  • 11:09 --> 11:13But just that since they have fewer
  • 11:13 --> 11:16skin cancers in sun exposed areas,
  • 11:16 --> 11:19that is an important
  • 11:19 --> 11:21place to check for higher and
  • 11:21 --> 11:23darker skin types including mine.
  • 11:23 --> 11:27So but what I would say is,
  • 11:27 --> 11:30that there are major differences
  • 11:30 --> 11:33and so another major difference is
  • 11:33 --> 11:36that higher or darker skin types and
  • 11:36 --> 11:39I say higher because we kind of have a
  • 11:39 --> 11:41Fitzpatrick skin color scale which kind
  • 11:41 --> 11:45of gives you a number for the skin color,
  • 11:45 --> 11:48the skin type that you have and
  • 11:48 --> 11:51lightest or fairest is close to 0
  • 11:51 --> 11:52Melanin and pigment.
  • 11:52 --> 11:54That color that makes brown in the
  • 11:54 --> 11:56skin or tan in the skin is A1.
  • 11:56 --> 11:59And then the higher skin type is
  • 11:59 --> 12:026 it goes up to six is darker skin,
  • 12:02 --> 12:04the darkest that has the most melanin in it.
  • 12:04 --> 12:06And it's also based on how your
  • 12:06 --> 12:08skin reacts to sunlight.
  • 12:08 --> 12:10So if you basically burn and hardly
  • 12:10 --> 12:12really tan at all don't get darker,
  • 12:12 --> 12:14you're a one.
  • 12:14 --> 12:15And if you essentially never,
  • 12:15 --> 12:16never ever burn,
  • 12:16 --> 12:18but you do get a little darker from the
  • 12:18 --> 12:20sun that's a six and in the middle 3-4,
  • 12:20 --> 12:22it's like you generally tan
  • 12:22 --> 12:23but you can burn.
  • 12:23 --> 12:25And so that's the scale
  • 12:25 --> 12:26that I'm talking about and why
  • 12:26 --> 12:28I'll say higher skin types.
  • 12:28 --> 12:31And so if you have higher skin types
  • 12:31 --> 12:35we'll think like 4-5 and six,
  • 12:35 --> 12:38you tend to get Melanoma for example
  • 12:38 --> 12:40under your nails more so than if
  • 12:40 --> 12:43you have lower skin types or on the
  • 12:43 --> 12:45bottoms of the feet or on the palms
  • 12:45 --> 12:47or you know for example in that
  • 12:47 --> 12:49genital area as we talked about.
  • 12:49 --> 12:52So I really emphasize to my patients
  • 12:52 --> 12:54with higher skin types to definitely
  • 12:54 --> 12:57definitely look in those areas as well.
  • 12:57 --> 13:00And so I think that sort of myth
  • 13:00 --> 13:03or misconception that it's sun
  • 13:03 --> 13:05exposed areas may also contribute
  • 13:05 --> 13:07to the statistics that we know
  • 13:07 --> 13:09that are true that patients with
  • 13:09 --> 13:11higher skin types often have their
  • 13:11 --> 13:13skin cancers not often,
  • 13:13 --> 13:16but maybe can have for sure their skin
  • 13:16 --> 13:19cancers detected later than fair skin types.
  • 13:19 --> 13:21And I think it might be because
  • 13:21 --> 13:22of that myth or misconception that
  • 13:22 --> 13:24people don't think you can have
  • 13:24 --> 13:26a skin cancer under your nail or
  • 13:26 --> 13:28on the bottom of your feet,
  • 13:28 --> 13:29which generally isn't being
  • 13:29 --> 13:30exposed to the sun either,
  • 13:30 --> 13:33or the genital perigenital area.
  • 13:33 --> 13:35Yeah, I was going to ask you that
  • 13:35 --> 13:36question in terms of
  • 13:36 --> 13:38the fact that we simply don't
  • 13:38 --> 13:39think to check in those areas.
  • 13:39 --> 13:41So that may contribute to
  • 13:41 --> 13:43these being picked up later.
  • 13:43 --> 13:46We are going to continue this very
  • 13:46 --> 13:48interesting conversation right after we
  • 13:48 --> 13:50take a short break for a medical minute.
  • 13:50 --> 13:52Please stay tuned to learn more about
  • 13:52 --> 13:54the care of patients with Melanoma
  • 13:54 --> 13:56and other skin cancers in honor of
  • 13:56 --> 13:58Melanoma and skin cancer awareness Month
  • 13:58 --> 14:00with my guest Doctor Christine Ko.
  • 14:01 --> 14:03Funding for Yale Cancer Answers
  • 14:03 --> 14:05comes from Smilow Cancer Hospital,
  • 14:05 --> 14:07where their Melanoma program
  • 14:07 --> 14:09brings together an extensive
  • 14:09 --> 14:10multidisciplinary team to diagnose,
  • 14:10 --> 14:13treat, and care for patients with
  • 14:13 --> 14:15Melanoma and other skin cancers.
  • 14:15 --> 14:19Smilowcancerhospital.org.
  • 14:19 --> 14:21It's estimated that over 240,000
  • 14:21 --> 14:23men in the US will be diagnosed
  • 14:23 --> 14:26with prostate cancer this year,
  • 14:26 --> 14:28with over 3000 new cases being
  • 14:28 --> 14:30identified here in Connecticut.
  • 14:30 --> 14:32One in eight American men will
  • 14:32 --> 14:33develop prostate cancer in
  • 14:33 --> 14:35the course of his lifetime.
  • 14:35 --> 14:37Major advances in the detection and
  • 14:37 --> 14:39treatment of prostate cancer have
  • 14:39 --> 14:40dramatically decreased the number
  • 14:40 --> 14:42of men who die from the disease.
  • 14:42 --> 14:44Screening can be performed quickly
  • 14:44 --> 14:46and easily in a physician's
  • 14:46 --> 14:48office using two simple tests,
  • 14:48 --> 14:50a physical exam and a blood test.
  • 14:50 --> 14:52Clinical trials are currently underway
  • 14:52 --> 14:54at federally designated Comprehensive
  • 14:54 --> 14:57Cancer centers such as Yale Cancer
  • 14:57 --> 14:59Center and Smilow Cancer Hospital
  • 14:59 --> 15:01where doctors are also using
  • 15:01 --> 15:02the Artemis machine,
  • 15:02 --> 15:04which enables targeted biopsies
  • 15:04 --> 15:05to be performed.
  • 15:05 --> 15:07More information is available
  • 15:07 --> 15:09at yalecancercenter.org.
  • 15:09 --> 15:13You're listening to Connecticut Public Radio.
  • 15:13 --> 15:13Welcome
  • 15:13 --> 15:15back to Yale Cancer Answers.
  • 15:15 --> 15:17This is Doctor Anees Chagpar,
  • 15:17 --> 15:19and I'm joined tonight by my guest,
  • 15:19 --> 15:20Doctor Christine Ko.
  • 15:20 --> 15:23We're talking about the care of patients with
  • 15:23 --> 15:26Melanoma and other skin cancers in honor of
  • 15:26 --> 15:29Melanoma and Skin Cancer Awareness Month.
  • 15:29 --> 15:30Now, right before the break, Christine,
  • 15:30 --> 15:34you were mentioning that some people,
  • 15:34 --> 15:36particularly those who
  • 15:36 --> 15:38have higher skin types,
  • 15:38 --> 15:42that is to say darker skin with more melanin,
  • 15:42 --> 15:44tend to get fewer skin cancers,
  • 15:44 --> 15:48but may have proportionately more in
  • 15:48 --> 15:51places that people often don't look.
  • 15:51 --> 15:52So under the nails,
  • 15:52 --> 15:54the bottom of the feet,
  • 15:54 --> 15:55the genital areas.
  • 15:55 --> 15:58Non skin exposed areas that
  • 15:58 --> 16:00still can get skin cancers.
  • 16:00 --> 16:03And so really important for people to
  • 16:03 --> 16:06look because one of the very important
  • 16:06 --> 16:08points that I think you made right
  • 16:08 --> 16:11as we were going to break was that
  • 16:11 --> 16:15these can be found at a later stage.
  • 16:15 --> 16:17And so the question that
  • 16:17 --> 16:20then leads into is
  • 16:20 --> 16:22can you talk a little bit more
  • 16:22 --> 16:24about the treatment algorithms
  • 16:24 --> 16:25for treating Melanoma?
  • 16:25 --> 16:28Stage is something that we'll use to
  • 16:28 --> 16:31refer to how advanced a cancer is.
  • 16:31 --> 16:35And really the goal of I think
  • 16:35 --> 16:36physicians, dermatologists,
  • 16:36 --> 16:39anyone who deals with cancer is to
  • 16:39 --> 16:42detect it as early as possible and
  • 16:42 --> 16:44so that you have early stage cancer,
  • 16:44 --> 16:46people might be more
  • 16:46 --> 16:47familiar with breast cancer.
  • 16:47 --> 16:49But same thing applies to
  • 16:49 --> 16:51Melanoma or other cancers.
  • 16:51 --> 16:53And stage one cancer or even
  • 16:53 --> 16:56to stage zero
  • 16:56 --> 16:59is the best to have rather than
  • 16:59 --> 17:01stage 4 which means that you have
  • 17:01 --> 17:04cancer that has spread and so Melanoma
  • 17:04 --> 17:07can definitely be stage 4, stage 3,
  • 17:07 --> 17:09these higher stages that suggest that
  • 17:09 --> 17:12you're going to have a worse prognosis
  • 17:12 --> 17:14meaning that cancer really
  • 17:14 --> 17:16might affect the course of your life.
  • 17:16 --> 17:20And so ideally when we catch skin cancer
  • 17:20 --> 17:22including Melanoma at stage zero,
  • 17:22 --> 17:24stage 1 or even stage two,
  • 17:24 --> 17:26we can cure the patient.
  • 17:26 --> 17:30Usually the best way is just to cut it out.
  • 17:30 --> 17:33And so it sort of
  • 17:33 --> 17:35comes down to math, right?
  • 17:35 --> 17:38If you imagine something smaller,
  • 17:38 --> 17:40it's much easier to cut it
  • 17:40 --> 17:41out no matter where it is,
  • 17:41 --> 17:43even if it's in a sensitive area.
  • 17:43 --> 17:47Like the genital area and the bigger it is,
  • 17:47 --> 17:49the harder it is to cut
  • 17:49 --> 17:50that larger thing out.
  • 17:50 --> 17:52So excision or cutting something out
  • 17:52 --> 17:55is the main way we treat things and
  • 17:55 --> 17:58it works often very well and many,
  • 17:58 --> 17:59many people have a cure.
  • 17:59 --> 18:01And so I'll often tell people that,
  • 18:01 --> 18:02for example BCC,
  • 18:02 --> 18:04the basal cell carcinoma that
  • 18:04 --> 18:05we mentioned in the first part,
  • 18:05 --> 18:08that often is cured very easily,
  • 18:08 --> 18:10relatively easily compared to other
  • 18:10 --> 18:13skin cancers with a simple excision.
  • 18:13 --> 18:14And people do very well.
  • 18:14 --> 18:16And so it's the best cancer to
  • 18:16 --> 18:18have is what I'll tell patients
  • 18:18 --> 18:19if you have to have one.
  • 18:19 --> 18:21Melanoma often can also be
  • 18:21 --> 18:22cured with excision.
  • 18:22 --> 18:24Other ways especially for
  • 18:24 --> 18:27higher stages is
  • 18:27 --> 18:28newer modalities,
  • 18:28 --> 18:30there's been an explosion,
  • 18:30 --> 18:32a really wonderful explosion in
  • 18:32 --> 18:34cancer treatment for all cancers,
  • 18:34 --> 18:36but also including Melanoma.
  • 18:36 --> 18:38And we used to not have great
  • 18:38 --> 18:41treatments for advanced stage Melanoma,
  • 18:41 --> 18:43stage 3 or stage 4.
  • 18:43 --> 18:45But increasingly we have new
  • 18:45 --> 18:47treatments including something
  • 18:47 --> 18:49called BRAF inhibitor treatment,
  • 18:50 --> 18:51also MECH inhibitor treatment.
  • 18:51 --> 18:53And they all have fancy names
  • 18:55 --> 18:58but the important thing to remember
  • 18:58 --> 19:01is that increasingly with help of
  • 19:01 --> 19:03researchers and scientists and
  • 19:03 --> 19:05physicians who dedicate their time
  • 19:05 --> 19:08to research as well in laboratories
  • 19:08 --> 19:11that there are molecular alterations,
  • 19:11 --> 19:13there's alterations on that inside
  • 19:13 --> 19:15cell level that are detected.
  • 19:15 --> 19:17And so for Melanoma,
  • 19:17 --> 19:19an example is a BRAF mutation,
  • 19:19 --> 19:22BRAF is a particular gene
  • 19:22 --> 19:24in our genetic code that can
  • 19:24 --> 19:25be changed in skin cancer,
  • 19:25 --> 19:28in Melanoma and a drug
  • 19:28 --> 19:30targets that
  • 19:30 --> 19:32particular BRAF mutation.
  • 19:32 --> 19:34And so we have these advances
  • 19:34 --> 19:36that can do wonders even with
  • 19:36 --> 19:38stage 4 with metastatic Melanoma.
  • 19:38 --> 19:41And so I would just say work
  • 19:41 --> 19:43carefully and closely
  • 19:43 --> 19:45with your oncologist and
  • 19:45 --> 19:46you'll see that oftentimes there
  • 19:46 --> 19:48can be really great treatments.
  • 19:48 --> 19:50So you know, when you talk about these
  • 19:50 --> 19:53fancy drugs that are
  • 19:53 --> 19:56inhibitors of various mutations,
  • 19:56 --> 19:58it certainly sounds a lot like
  • 19:58 --> 20:00the precision medicine that
  • 20:00 --> 20:03we've talked about on this show
  • 20:03 --> 20:05previously for other cancers.
  • 20:05 --> 20:07Can you tell us a little bit more
  • 20:07 --> 20:10about how common these mutations are
  • 20:10 --> 20:12in Melanoma because it's still the
  • 20:12 --> 20:15perception of many that Melanoma is
  • 20:15 --> 20:18the most deadly skin cancer.
  • 20:18 --> 20:21But if the majority of these have
  • 20:21 --> 20:26a targetable mutation and if those
  • 20:26 --> 20:28drugs that are inhibitors of those
  • 20:28 --> 20:31targetable mutations are very effective,
  • 20:31 --> 20:33one can imagine that it might not
  • 20:33 --> 20:35actually be as deadly as some think.
  • 20:36 --> 20:38Absolutely. And that's why I said
  • 20:38 --> 20:41there's this wonderful explosion of new
  • 20:41 --> 20:44treatments because we are seeing that.
  • 20:44 --> 20:46When I started out,
  • 20:46 --> 20:48and even probably for a good half
  • 20:48 --> 20:50of my career as a dermatologist,
  • 20:50 --> 20:53if someone was diagnosed
  • 20:53 --> 20:54with advanced Melanoma,
  • 20:54 --> 20:57Stage 4 Melanoma that had spread,
  • 20:57 --> 21:01that was pretty much a fatal diagnosis.
  • 21:01 --> 21:04A really difficult conversation to have
  • 21:04 --> 21:07with that patient about what was sort
  • 21:07 --> 21:10of in store in terms of that cancer.
  • 21:10 --> 21:11There were treatments,
  • 21:11 --> 21:13say like interferon alpha.
  • 21:13 --> 21:16But they didn't work that well and in
  • 21:16 --> 21:19the vast majority of patients.
  • 21:19 --> 21:21So now what we're seeing is
  • 21:21 --> 21:23with that personalized medicine,
  • 21:23 --> 21:24absolutely your cancer,
  • 21:24 --> 21:27your Melanoma can be sequenced
  • 21:27 --> 21:29and even just stained.
  • 21:29 --> 21:32So now for that BRAF gene for example,
  • 21:32 --> 21:34we have an immunohistochemical
  • 21:34 --> 21:37stain which just means that your
  • 21:37 --> 21:40pathologist or dramatopathologist can
  • 21:40 --> 21:42stain the tissue with a particular
  • 21:42 --> 21:45antibody and just see if the tissue
  • 21:45 --> 21:47lights up a different color showing that
  • 21:47 --> 21:50the antibody, that protein, is stained.
  • 21:50 --> 21:52And so then that would suggest that
  • 21:52 --> 21:54that personalized treatment with a
  • 21:54 --> 21:57BRAF inhibitor would work versus if your
  • 21:57 --> 21:59tissue doesn't stain,
  • 21:59 --> 22:00it wouldn't work.
  • 22:00 --> 22:03So we can get more and more precise and
  • 22:03 --> 22:05personalized for the best treatment
  • 22:05 --> 22:08to use on patients and so there are these
  • 22:08 --> 22:10really stunning curves in science
  • 22:10 --> 22:12journals that will show survival curves
  • 22:12 --> 22:15and they're called waterfall plots.
  • 22:15 --> 22:17It's kind of a pretty fancy
  • 22:17 --> 22:18kind of picturesque term,
  • 22:18 --> 22:21but it really shows that survival has really
  • 22:21 --> 22:24changed with newer medicines like that.
  • 22:24 --> 22:26And I just want to again emphasize though
  • 22:26 --> 22:29that early detection is still better because
  • 22:29 --> 22:32what happens with some of these medicines,
  • 22:32 --> 22:33for example,
  • 22:33 --> 22:35that BRAF inhibitor medicine
  • 22:36 --> 22:38it's tricky and it's growing fast
  • 22:39 --> 22:41because it's out of control, right?
  • 22:41 --> 22:42That's what cancer is,
  • 22:42 --> 22:44uncontrolled growth and it can bypass,
  • 22:44 --> 22:48it can start to bypass around that treatment.
  • 22:48 --> 22:50So the earlier we can detect it,
  • 22:50 --> 22:52the fewer cells of cancer that there are,
  • 22:52 --> 22:55there's less chance of that kind of
  • 22:55 --> 22:57resistance to treatment developing.
  • 23:03 --> 23:06Most melanomas have these mutations
  • 23:06 --> 23:09such that they are targetable or
  • 23:09 --> 23:12are many of them without a target
  • 23:12 --> 23:15such that they need to be treated
  • 23:15 --> 23:18with more generalized therapies like
  • 23:18 --> 23:21chemotherapy or immunotherapy, yes.
  • 23:21 --> 23:23So I would say the majority,
  • 23:23 --> 23:26maybe 60% plus of melanomas can
  • 23:26 --> 23:30have a targetable BRAF mutation.
  • 23:33 --> 23:35Studies showed
  • 23:35 --> 23:37relatively early on that treatment with
  • 23:37 --> 23:40a BRAF inhibitor alone resistance
  • 23:40 --> 23:42would often develop within sort of
  • 23:42 --> 23:44less than a year's time in patients.
  • 23:44 --> 23:48So now immunotherapy and
  • 23:48 --> 23:51adding on other medicines on top of a
  • 23:51 --> 23:54BRAF inhibitor is commonly used and
  • 23:54 --> 23:57is very effective and can prevent
  • 23:57 --> 23:59that kind of resistance from
  • 23:59 --> 24:00forming, absolutely.
  • 24:01 --> 24:04And so how many of these patients
  • 24:04 --> 24:08who have a BRAF mutation who are
  • 24:08 --> 24:12treated with targeted therapies then
  • 24:12 --> 24:16relapse and I mean do we see
  • 24:16 --> 24:18you mentioned that if they relapse,
  • 24:18 --> 24:20they generally relapse within a year
  • 24:20 --> 24:23but do many of them never relapse,
  • 24:23 --> 24:26I mean is this truly curative treatment?
  • 24:27 --> 24:30Yeah, there are definitely success
  • 24:30 --> 24:32stories where there's a cure.
  • 24:32 --> 24:35Some patients do need to stay
  • 24:35 --> 24:37on that immunotherapy that inhibitor,
  • 24:37 --> 24:40but it can keep
  • 24:40 --> 24:43the cancer in check basically.
  • 24:43 --> 24:45So yes, there are cures,
  • 24:45 --> 24:47close to being cures or sort
  • 24:47 --> 24:49of control of the disease,
  • 24:49 --> 24:51yes and they're stunning.
  • 24:51 --> 24:53Other patients may not have
  • 24:53 --> 24:55as good a response rate and
  • 24:55 --> 24:59I would say it is still to me
  • 24:59 --> 25:01also part of personalized medicine
  • 25:01 --> 25:02entails that your response
  • 25:02 --> 25:05becomes what it is for you.
  • 25:05 --> 25:07So there are statistics,
  • 25:07 --> 25:09but good careful follow up and
  • 25:09 --> 25:12follow up of any scans if you have them.
  • 25:12 --> 25:14That kind of periodic monitoring
  • 25:14 --> 25:17is probably at least right
  • 25:17 --> 25:18now still always important.
  • 25:19 --> 25:21And when you mention that some
  • 25:21 --> 25:24patients need to take immunotherapy
  • 25:24 --> 25:27to kind of keep this cancer under control
  • 25:27 --> 25:30is that given orally and how long do
  • 25:30 --> 25:33patients need to be on those therapies?
  • 25:34 --> 25:35Yes, immunotherapy.
  • 25:35 --> 25:37There are things like PD1 inhibitors
  • 25:37 --> 25:41which are used for other cancers as well.
  • 25:41 --> 25:43So people may be familiar with them
  • 25:43 --> 25:46in other in the context of other
  • 25:46 --> 25:48cancers like colon cancer or lung
  • 25:48 --> 25:51cancer or other organ systems.
  • 25:51 --> 25:53And they're generally infusions, yes.
  • 25:53 --> 25:56So you would still go
  • 25:59 --> 26:02get an IV put in and it would be
  • 26:02 --> 26:04infused through your vein.
  • 26:05 --> 26:08Getting back to where we started
  • 26:08 --> 26:09this conversation, you know,
  • 26:09 --> 26:12we talked to at the top of the show
  • 26:12 --> 26:15about the spectrum of cancers and you
  • 26:15 --> 26:18mentioned that the majority of cancers
  • 26:18 --> 26:20are actually basal cell cancers.
  • 26:20 --> 26:23And many of us may not talk a lot
  • 26:23 --> 26:25about basal cell cancers because they
  • 26:25 --> 26:28generally have a really good prognosis.
  • 26:28 --> 26:29Is that right?
  • 26:30 --> 26:33Yes. Basal cell cancer especially
  • 26:33 --> 26:35when detected early, it's less
  • 26:35 --> 26:37than you know say a centimeter,
  • 26:37 --> 26:41it's highly curable with excision.
  • 26:41 --> 26:43Then they don't require
  • 26:43 --> 26:44any further treatment?
  • 26:44 --> 26:48Generally not.
  • 26:48 --> 26:51And so how can yoy
  • 26:51 --> 26:53kind of guide our audience
  • 26:53 --> 26:55when we're doing those very thorough
  • 26:55 --> 26:57skin exams once a month that you had
  • 26:57 --> 27:00mentioned in the first half of the show,
  • 27:00 --> 27:02what should we be looking for in
  • 27:02 --> 27:06terms of a basal cell versus a
  • 27:06 --> 27:09squamous cell versus a Melanoma?
  • 27:09 --> 27:10And when should we really be
  • 27:10 --> 27:12going to our doctor and saying,
  • 27:12 --> 27:14hey, look at this because,
  • 27:14 --> 27:17many of us will have little spots,
  • 27:17 --> 27:18moles, you know,
  • 27:18 --> 27:20maybe a freckle or two.
  • 27:20 --> 27:22And we really don't want to bother
  • 27:22 --> 27:24our doctor if we don't think it's
  • 27:24 --> 27:26anything to be concerned about.
  • 27:26 --> 27:28But at the same time,
  • 27:28 --> 27:30we want to be sure that we're detecting
  • 27:30 --> 27:33anything that might be a cancer early.
  • 27:33 --> 27:35So can you kind of give us some tips?
  • 27:36 --> 27:38It's interesting because Melanoma,
  • 27:38 --> 27:41which people are more aware, most aware of,
  • 27:41 --> 27:43it seems like when I talk to my patients
  • 27:43 --> 27:45it's great that they're aware of that,
  • 27:45 --> 27:48but in the sense that Melanoma often
  • 27:48 --> 27:52looks very different than other skin cancers,
  • 27:52 --> 27:53especially BCC, basal cell carcinoma,
  • 27:53 --> 27:55which is the most common as
  • 27:55 --> 27:56we've been talking about.
  • 27:56 --> 27:58And so basal cell carcinoma,
  • 27:58 --> 28:02what you want to look for that
  • 28:02 --> 28:04pink to sort of translucent
  • 28:04 --> 28:06to sometimes dark,
  • 28:06 --> 28:08it can sometimes be Gray or black,
  • 28:08 --> 28:09especially in patients
  • 28:09 --> 28:11with higher skin types.
  • 28:11 --> 28:14That 4-5 or six Fitzpatrick scale,
  • 28:14 --> 28:15it can be Gray.
  • 28:15 --> 28:17So not everything that's dark
  • 28:17 --> 28:18and irregular is Melanoma.
  • 28:18 --> 28:22Sometimes it is BCC basal cell carcinoma.
  • 28:22 --> 28:24So a general rule of thumb
  • 28:24 --> 28:26that I'll tell patients is
  • 28:26 --> 28:28let me know about, let your dermatologist
  • 28:28 --> 28:30know your physician know about
  • 28:30 --> 28:32anything that looks weird to you.
  • 28:33 --> 28:35Doctor Christine Ko is a professor
  • 28:35 --> 28:37of dermatology and pathology at
  • 28:37 --> 28:39the Yale School of Medicine.
  • 28:39 --> 28:41If you have questions, the address
  • 28:41 --> 28:43is Cancer Answers at Yale dot Edu,
  • 28:43 --> 28:46and past editions of the program
  • 28:46 --> 28:48are available in audio and written
  • 28:48 --> 28:49form at yalecancercenter.org.
  • 28:49 --> 28:51We hope you'll join us next week to
  • 28:51 --> 28:53learn more about the fight against
  • 28:53 --> 28:55cancer here on Connecticut Public Radio.
  • 28:55 --> 28:57Funding for Yale Cancer Answers is
  • 28:57 --> 29:00provided by Smilow Cancer Hospital.